Standout Papers
- Doxorubicin pathways (2010)
- Pharmacogenomics — Drug Disposition, Drug Targets, and Side Effects (2003)
- Effect of VKORC1 Haplotypes on Transcriptional Regulation and Warfarin Dose (2005)
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update (2017)
- Genomics and Drug Response (2011)
- The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update (2014)
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy (2018)
- Pharmacogenomics (2019)
Immediate Impact
6 by Nobel laureates 12 from Science/Nature 63 standout
Citing Papers
Theranostic Fluorescent Probes
2024 Standout
Accurate proteome-wide missense variant effect prediction with AlphaMissense
2023 StandoutScienceNobel
Works of Howard L. McLeod being referenced
Opportunities, resources, and techniques for implementing genomics in clinical care
2019
Nomenclature for alleles of the thiopurine methyltransferase gene
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Howard L. McLeod | 9953 | 9356 | 6442 | 476 | 26.0k | |
| Mark J. Ratain | 10113 | 9035 | 2791 | 528 | 22.7k | |
| Jan H.M. Schellens | 22295 | 15780 | 3493 | 878 | 40.3k | |
| Alex Sparreboom | 14048 | 8766 | 3220 | 401 | 23.9k | |
| Teri E. Klein | 4637 | 6937 | 12310 | 349 | 28.9k | |
| Henk‐Jan Guchelaar | 4429 | 3974 | 3508 | 443 | 15.1k | |
| Susan E. Bates | 22612 | 19797 | 1534 | 440 | 37.9k | |
| William E. Evans | 6661 | 9240 | 5644 | 381 | 33.3k | |
| Roger Williams | 3405 | 14055 | 2857 | 817 | 45.0k | |
| Mary V. Relling | 7456 | 8420 | 7164 | 379 | 32.6k | |
| William D. Figg | 9855 | 11342 | 1316 | 599 | 24.6k |
All Works
Login with ORCID to disown or claim papers
Loading papers...